U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Capecitabine Tablets
Status: Currently in Shortage
»Date first posted: 02/09/2023
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 02/17/2023)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 120 count (NDC 16729-073-29) Unavailable Blue Point (NDC 680010-488-07) and NorthStar (NDC 16714-468-01) manufactured by Accord - Unavailable Other

Dr. Reddy’s Laboratories, Inc (New 02/17/2023)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
150 mg 60's USA (NDC 55111-496-60) Available
500 mg 120's USA (NDC 55111-497-04) Available

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 05/31/2023)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
150 mg, 60 ct (NDC 59651-204-60) On allocation Intermittent availability expected Demand increase for the drug
150 mg, 1x10 unit (NDC 59651-204-10) Not Marketed
500 mg, 120 ct (NDC 59651-205-08) On allocation Intermittent availability expected Demand increase for the drug
500 mg, 1x10 unit (NDC 59651-205-10) Not Marketed

Genentech (Revised 02/10/2023)

Company Contact Information:
800-551-2231

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Xeloda 150 mg tablets (NDC 0004-1100-20) Limited supply available
Xeloda 500 mg tablets (NDC 0004-1101-50) Available

Novadoz Pharmaceuticals LLC (Revised 02/10/2023)

Company Contact Information:
848-200-1906

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 120 count (NDC 72205-007-92) Available Manufactured by MSN Laboratories Private Limited (Formulation Division)
150 mg, 60 count (NDC 72205-006-60) Available Manufactured by MSN Laboratories Private Limited (Formulation Division)

Teva Pharmaceuticals (Reverified 05/23/2023)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
150 mg, 60 count (NDC 0093-7473-06) Available Demand increase for the drug
500 mg, 120 count (NDC 0093-7474-89) Available Demand increase for the drug
Back to Top